These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2053772

  • 1. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H, Kubota T, Takahara T, Takeuchi T, Furukawa T, Kase S, Josui K, Kodaira S, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1135-41. PubMed ID: 2053772
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K, Akamatsu K, Matsumoto T, Morikawa K, Honda M, Mitsui H, Koizumi M, Koizumi K, Matsuno T.
    Anticancer Res; 1989 Jun; 9(4):987-91. PubMed ID: 2817826
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Jun; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 4. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T.
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):73-8. PubMed ID: 2404458
    [Abstract] [Full Text] [Related]

  • 5. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
    Ariyoshi Y, Ota K.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T.
    Gan To Kagaku Ryoho; 1989 May; 16(5):2039-43. PubMed ID: 2658840
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Anticancer Res; 1991 May; 11(2):761-7. PubMed ID: 2064331
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 30; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 10. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M, Ozaki M, Hongo J, Hirota Y, Inagaki M, Taniguchi H, Tateishi R, Mori Y.
    Gan To Kagaku Ryoho; 1987 Mar 30; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [Abstract] [Full Text] [Related]

  • 11. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
    Sawada M, Ozaki M, Taniguchi H, Tateishi R, Mori Y, Mino K.
    Gan To Kagaku Ryoho; 1988 Apr 30; 15(4 Pt 1):637-41. PubMed ID: 3355185
    [Abstract] [Full Text] [Related]

  • 12. Lung tumour growth delay and normal tissue toxicity induced by three cytotoxic platinum drugs.
    van Rongen E, Kal HB, Kuijpers WC, van Berkel AH.
    Strahlenther Onkol; 1992 May 30; 168(5):300-7. PubMed ID: 1598667
    [Abstract] [Full Text] [Related]

  • 13. [The prospect for cisplatin analogs from the experimental standpoint].
    Tashiro T.
    Gan To Kagaku Ryoho; 1989 Apr 30; 16(4 Pt 2-2):1358-65. PubMed ID: 2543305
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ.
    Cancer Res; 1983 Oct 30; 43(10):4927-34. PubMed ID: 6683993
    [Abstract] [Full Text] [Related]

  • 15. [Development of platinum analogues for the treatment of lung cancer].
    Nakai Y.
    Gan To Kagaku Ryoho; 1992 Nov 30; 19(13):2157-62. PubMed ID: 1332625
    [Abstract] [Full Text] [Related]

  • 16. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H, Meyer S, Shalet SM, Anderson E, Roberts S, Eden OB.
    Med Pediatr Oncol; 2002 Dec 30; 39(6):573-80. PubMed ID: 12376980
    [Abstract] [Full Text] [Related]

  • 17. [Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Gan To Kagaku Ryoho; 1992 Feb 30; 19(2):223-8. PubMed ID: 1736834
    [Abstract] [Full Text] [Related]

  • 18. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1993 Feb 30; 13(6A):2261-5. PubMed ID: 8297143
    [Abstract] [Full Text] [Related]

  • 19. [Experimental evaluation of cisplatin analogous in urogenital cancer].
    Machida T, Akasaka Y.
    Gan To Kagaku Ryoho; 1989 Apr 30; 16(4 Pt 2-2):1386-92. PubMed ID: 2658827
    [Abstract] [Full Text] [Related]

  • 20. Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivatives.
    Feng Z, Lai Y, Ye H, Huang J, Xi XG, Wu Z.
    Cancer Sci; 2010 Nov 30; 101(11):2476-82. PubMed ID: 20813014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.